Mechanisms and clinical implications of renal drug excretion

被引:92
作者
Masereeuw, R [1 ]
Russel, FGM [1 ]
机构
[1] Univ Med Ctr Nijmegen, Dept Pharmacol & Toxicol 233, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1081/DMR-120000654
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The body defends itself against potentially harmful compounds like drugs, toxic compounds, and their metabolites by elimination, in which the kidney plays an important role. Renal clearance is used to determine renal elimination mechanisms of a drug, which is the result of glomerular filtration, active tubular secretion and reabsorption. The renal proximal tubule is the primary site of carrier-mediated transport from blood to urine. Renal secretory mechanisms exists for, anionic compounds and organic cations. Both systems comprises several transport proteins, and knowledge of the molecular identity of these transporters and their substrate specificity has increased considerably in the past decade. Due to overlapping specificities of the transport proteins, drug interactions at the level of tubular secretion is an event that may occur in clinical situation. This review describes the different processes that determine renal drug handling, the techniques that have been developed to attain more insight in the various aspects of drug excretion, the functional characteristics of the individual transport proteins, and finally the implications of drug interactions in a clinical perspective.
引用
收藏
页码:299 / 351
页数:53
相关论文
共 395 条
[111]   Adenosine triphosphate-dependent transport of estradiol-17β(β-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells [J].
Hang, LY ;
Hoffman, T ;
Vore, M .
HEPATOLOGY, 1998, 28 (05) :1371-1377
[112]  
HARDY BG, 1988, INT J CLIN PHARM TH, V26, P388
[113]   MOMENT ANALYSIS OF DRUG DISPOSITION IN KIDNEY .6. ASSESSMENT OF INVIVO TRANSMEMBRANE TRANSPORT OF PARA-AMINOHIPPURATE IN TUBULAR EPITHELIUM [J].
HE, YL ;
TANIGAWARA, Y ;
KAMIYA, A ;
HORI, R .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1991, 19 (06) :667-690
[114]   PROBENECID INHIBITS THE METABOLIC AND RENAL CLEARANCES OF ZIDOVUDINE (AZT) IN HUMAN VOLUNTEERS [J].
HEDAYA, MA ;
ELMQUIST, WF ;
SAWCHUK, RJ .
PHARMACEUTICAL RESEARCH, 1990, 7 (04) :411-417
[115]  
HEDIGER MA, 1995, J PHYSIOL-LONDON, V482P, pS7
[116]   Increased urinary excretion of carnitine in patients treated with cisplatin [J].
Heuberger, W ;
Berardi, S ;
Jacky, E ;
Pey, P ;
Krähenbühl, S .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (07) :503-508
[117]   EARLY RENAL MEDULLARY HYPOXIC INJURY FROM RADIOCONTRAST AND INDOMETHACIN [J].
HEYMAN, SN ;
BREZIS, M ;
EPSTEIN, FH ;
SPOKES, K ;
SILVA, P ;
ROSEN, S .
KIDNEY INTERNATIONAL, 1991, 40 (04) :632-642
[118]   ACUTE RENAL-FAILURE WITH SELECTIVE MEDULLARY INJURY IN THE RAT [J].
HEYMAN, SN ;
BREZIS, M ;
REUBINOFF, CA ;
GREENFELD, Z ;
LECHENE, C ;
EPSTEIN, FH ;
ROSEN, S .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (02) :401-412
[119]  
HIGGINS JT, 1980, CLIN DISORDERS FLUID
[120]   CIMETIDINE IMPROVES THE RELIABILITY OF CREATININE AS A MARKER OF GLOMERULAR-FILTRATION [J].
HILBRANDS, LB ;
ARTZ, MA ;
WETZELS, JFM ;
KOENE, RAP .
KIDNEY INTERNATIONAL, 1991, 40 (06) :1171-1176